The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 205-211

  Mak, Daisy ^a   Joon, Daryl Lim ^a   Chao, Michael ^b   Wada, Morikatsu ^a   Joon, Michael Lim ^a   See, Andrew ^a   Feigen, Malcolm ^a   Jenkins, Patricia ^a   Mercuri, Angelina ^a   McNamara, Joanne ^a   Poon, Aurora ^a   Khoo, Vincent ^a,c  

^a AUSTIN HEALTH   (Australia)

^b Radiation Oncology Victoria   (Australia)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

FDG PET; Follow up; Radiotherapy; Rectal carcinoma; Response; Staging

Indexed keywords

FLUORODEOXYGLUCOSE; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78149361784     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.05.016     Document Type: Article

References (32)

1. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001;358:1291-304.
2. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7.
3. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
4. N.A. Janjan, J. Abbruzzese, and R. Pazdur Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer Radiother Oncol 51 1999 153 160
5. N.A. Janjan, V.S. Khoo, and J. Abbruzzese Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M.D. Anderson Cancer Center experience Int J Radiat Oncol Biol Phys 44 1999 1027 1038
6. V. Valentini, C. Aristei, and B. Glimelius Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) Radiother Oncol 92 2009 148 163
7. J. Garcia-Aguilar, E. Hernandez de Anda, P. Sirivongs, S.H. Lee, R.D. Madoff, and D.A. Rothenberger A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 2003 298 304
8. A. Habr-Gama, R.O. Perez, and W. Nadalin Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 2004 711 717 discussion 717-18
9. C.C. Chen, R.C. Lee, J.K. Lin, L.W. Wang, and S.H. Yang How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 48 2005 722 728
10. T. Denecke, B. Rau, and K.T. Hoffmann Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 15 2005 1658 1666
11. K. Kubota From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology Ann Nucl Med 15 2001 471 486
12. V. Valentini, C. Coco, and N. Cellini Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies Int J Radiat Oncol Biol Phys 51 2001 371 383
13. J.P. Gerard, O. Chapet, and C. Nemoz Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial J Clin Oncol 21 2003 1119 1124
14. C.S. Nahas, T. Akhurst, and H. Yeung Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation Ann Surg Oncol 15 2008 704 711
15. K. Davey, A.G. Heriot, and J. Mackay The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer Dis Colon Rectum 51 2008 997 1003
16. M.C. Bassi, L. Turri, and G. Sacchetti FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer Int J Radiat Oncol Biol Phys 70 2008 1423 1426
17. H. Furukawa, H. Ikuma, and A. Seki Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer Gut 55 2006 1007 1011
18. J.M. Llamas-Elvira, A. Rodriguez-Fernandez, and J. Gutierrez-Sainz Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer Eur J Nucl Med Mol Imaging 34 2007 859 867
19. U. Tateishi, T. Maeda, T. Morimoto, M. Miyake, Y. Arai, and E.E. Kim Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer Eur J Nucl Med Mol Imaging 34 2007 1627 1634
20. V. Valentini, C. Coco, and A. Picciocchi Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 2002 664 674
21. A. Habr-Gama, R.O. Perez, and I. Proscurshim Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy J Gastrointest Surg 10 2006 1319 1328 discussion 1328-19
22. J.G. Guillem, J. Puig-La Calle Jr., and T. Akhurst Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography Dis Colon Rectum 43 2000 18 24
23. C. Kristiansen, A. Loft, and A.K. Berthelsen PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer Dis Colon Rectum 51 2008 21 25
24. C. Capirci, D. Rubello, and F. Chierichetti Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy AJR Am J Roentgenol 187 2006 W202 W208
25. V. Kalff, C. Duong, E.G. Drummond, J.P. Matthews, and R.J. Hicks Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery J Nucl Med 47 2006 14 22
26. C. Capirci, L. Rampin, and P.A. Erba Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy Eur J Nucl Med Mol Imaging 34 2007 1583 1593
27. C. Schiepers, K. Haustermans, K. Geboes, L. Filez, G. Bormans, and F. Penninckx The effect of preoperative radiation therapy on glucose utilization and cell kinetics in patients with primary rectal carcinoma Cancer 85 1999 803 811
28. U. Haberkorn, L.G. Strauss, and A. Dimitrakopoulou PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy J Nucl Med 32 1991 1485 1490
29. A. van Waarde, D.C. Cobben, and A.J. Suurmeijer Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model J Nucl Med 45 2004 695 700
30. H.A. Wieder, H. Geinitz, and R. Rosenberg PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer Eur J Nucl Med Mol Imaging 34 2007 878 883
31. G.L. Cascini, A. Avallone, and P. Delrio 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer J Nucl Med 47 2006 1241 1248
32. H.A. Wieder, B.L. Brucher, and F. Zimmermann Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 22 2004 900 908